Previous 10 |
FILAMENT HEALTH ANNOUNCES THIRD QUARTER 2023 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS Canada NewsWire VANCOUVER, BC , Nov. 14, 2023 /CNW/ - Filament Health Corp. (OTCQB:FLHLF) (NEO:FH) (FSE:7QS) ("Filament" or the "Company"), a clinical-stage natural ...
2023-07-19 13:58:33 ET Filament Health ( OTCQB:FLHLF ), a Canadian developer of psychedelic drugs, has agreed to merge with SPAC Jupiter Acquisition Corp. ( NASDAQ: JAQC ) through an all-stock deal that pegs the enterprise value of the combined company at $210M. Under the de...
FILAMENT HEALTH CORP. TO LIST ON NASDAQ THROUGH BUSINESS COMBINATION WITH JUPITER ACQUISITION CORPORATION Canada NewsWire Business combination ascribes Filament US$176 million in equity value representing US$0.85 per Filament share and reflects a pro forma enterprise v...
News, Short Squeeze, Breakout and More Instantly...
Jupiter Acquisition Corporation Company Name:
JAQC Stock Symbol:
NASDAQ Market:
2023-12-15 15:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Hobe Sound, FL, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Jupiter Acquisition Corporation (NASDAQ:JAQC) (“Jupiter”) today announced that it intends to reconvene and then adjourn, without conducting any business, the special meeting of stockholders of Jupiter (the “Business Combinat...
FILAMENT HEALTH ANNOUNCES ADJOURNMENT OF SPECIAL MEETING Canada NewsWire VANCOUVER, BC , Dec. 11, 2023 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) (" Filament " or the " Company "), a clinical‐stage natural psychedel...